Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AC Immune SA | IMR | Oct 4, 2024 | 3.00 | -2.60 |
Acacia Research Corporation | AZG2 | Oct 4, 2024 | 3.98 | +1.53 |
AcadeMedia | V8T | Oct 4, 2024 | 5.86 | +0.86 |
Acadia Healthcare Company, Inc. | 7RA | Oct 4, 2024 | 51.00 | -3.77 |
ACADIA Pharmaceuticals Inc. | DR6 | Oct 4, 2024 | 13.24 | -2.57 |
Acadia Realty Trust | WX1 | Oct 4, 2024 | 20.80 | +1.96 |
Acadian Timber Corp | 779 | Oct 4, 2024 | 11.60 | +1.75 |
Acanthe Developpement SA | ADX | Oct 4, 2024 | 0.33 | -0.61 |
Acarix | 7AC | Oct 4, 2024 | 0.02 | -14.89 |
Acast AB | 0PN | Oct 4, 2024 | 1.37 | -1.44 |
Acasti Pharma A | A1P0 | Oct 4, 2024 | 2.66 | -1.48 |
Accelerate Diagnostics | 1A80 | Oct 4, 2024 | 1.62 | 0.00 |
ACCELLERON IND. ADR/1 | ZH20 | Oct 4, 2024 | 44.60 | +1.36 |
Accent Resources NL | A2R | Oct 4, 2024 | 0.01 | 0.00 |
Accentis S.A. | D1Z | Oct 4, 2024 | 0.02 | +2.27 |
Accentro Real Estate AG | A4Y | Oct 4, 2024 | 0.37 | -6.03 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | Oct 4, 2024 | 331.00 | +0.46 |
Accesso Technology Group Plc | LQG | Oct 4, 2024 | 5.70 | -3.39 |
Acciona SA | AJ3 | Oct 4, 2024 | 123.40 | +1.48 |
Acco Brands Corporation | A3B | Oct 4, 2024 | 4.72 | +0.43 |
Accolade, Inc. | 4NE1 | Oct 4, 2024 | 3.30 | -2.37 |
Acconeer | 2LU | Oct 4, 2024 | 0.55 | +3.22 |
Accor | ACR1 | Oct 4, 2024 | 7.55 | +0.67 |
Accor SA | ACR | Oct 4, 2024 | 38.17 | +0.63 |
Accsys Technologies | 1D8 | Oct 4, 2024 | 0.56 | 0.00 |
Accuray Incorporated | XEJ | Oct 4, 2024 | 1.58 | 0.00 |
Ace Hardware Indonesia TBK | 4AH1 | Oct 4, 2024 | 0.04 | -2.22 |
ACE LIBERTY+STONE LS -,25 | 8MW | Oct 4, 2024 | 0.55 | -0.91 |
ACEA SpA | DCA | Oct 4, 2024 | 17.06 | -0.93 |
AcelRx Pharmaceuticals | R5XA | Oct 4, 2024 | 0.70 | -2.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.